Skip to main content

Jonathan Romanowsky

Sep 3, 2026

11:41
Like, I don't know, break down in your mind, like the basic ROI sort of like calculator for these sort of tests in your mind.
11:51
So the answer is a qualified yes.
11:54
The reimbursement or the financial reality for that product has to be how you model a new venture.
12:04
And sometimes you're frankly thinking five to 10 years out and working backwards and saying, okay, how does this product, when you bring this product to market, what are the financial incentives and realities with that test? For some tests, you're absolutely right.
12:20
It is, quote unquote, straight on reimbursement.
12:23
There is reimbursement for that test.
12:26
And you have to think about, okay, well, if the doctor buys this instrument and they run these many tests, how much do they get paid for that test? So they're paying the manufacturer, in the example you described, a certain amount of money per test or per assay.

24 MINS LATER

36:45
And, you know, is then the game that like, it's like first to market and then... you know, building the sales and momentum, that's then the game, or I don't know, just can you talk a little bit about when you know that there are other players that are going after the same market, is there always like just enough of a difference where, you know, your thesis is faster runtime or whatever, and their thesis is higher throughput, or I don't know, I'm making that sort of stuff up, but when there's multiple players, how do you sort of view that when you do your market research?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.